Elsevier now offers a series of derivative works based on the acclaimed Meyler’s Side Effect of Drugs, 15th Edition. These individual volumes are grouped by specialty to benefit the practicing biomedical researcher and/or clinician.
There has been significant progress in the development of targeted therapy drugs that act specifically on certain cancers, and that minimize damage to normal cells. Oncologists and cancer researchers will rely on this volume to determine effective drug treatments.
Oncologists and cancer researchers
Edited by Jeffrey K. Aronson, MA DPhil MBChB FRCP FBPharmacolS FFPM(Hon), Department of Primary Health Care, University of Oxford, Oxford, UK